Inogen (INGN) Change in Receivables (2013 - 2026)
Inogen's (INGN) quarterly Change in Receivables came in at $5.5 million in Q1 2026, down 32.79% year-on-year from $8.2 million in Q1 2025, and up 5534.65% on a QoQ basis from -$101000.0 in Q4 2025.
Inogen (INGN) Change in Receivables (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Change in Receivables data on file, last reported at $5.5 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 32.79% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $11.9 million, a 8.72% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, up 181.94% from the prior year.
- Change in Receivables for Q1 2026 stood at $5.5 million, up from -$101000.0 in the prior quarter.
- Over the last five years, Change in Receivables for INGN reached as high as $24.0 million in Q3 2022 and fell as low as -$6.7 million in Q1 2023.
- Historically, Change in Receivables has averaged $3.9 million across 5 years, with a median of $2.6 million in 2024.
- On a YoY basis, Change in Receivables climbed as much as 51080.0% in 2024 and fell as far as 299.05% in 2024.
- Year by year, Change in Receivables stood at $13.5 million in 2022, then plunged by 122.21% to -$3.0 million in 2023, then surged by 234.39% to $4.0 million in 2024, then plunged by 102.5% to -$101000.0 in 2025, then jumped by 5534.65% to $5.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $5.5 million in Q1 2026, -$101000.0 in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.49 Mn |
| Mar 31, 2026 | 5.49 Mn |
| Dec 31, 2025 | -101,000.00 |
| Dec 31, 2025 | -101,000.00 |
| Sep 30, 2025 | 3.69 Mn |
| Sep 30, 2025 | 3.69 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 8.17 Mn |
| Mar 31, 2025 | 8.17 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | -1.67 Mn |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | 267,000.00 |
| Mar 31, 2024 | 267,000.00 |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |